ZYDUS Company Profile

✉ Email this page to a colleague

ZYDUS has three hundred and seventy-eight approved drugs.

There is one US patent protecting ZYDUS drugs. There are twenty-six tentative approvals on ZYDUS drugs.

There are four patent family members on ZYDUS drugs in four countries and nine hundred and fifty-seven supplementary protection certificates in eighteen countries.

International Patents:	4
US Patents:	1
Tradenames:	306
Ingredients:	296
NDAs:	378
Patent Litigation for ZYDUS:	See patent lawsuits for ZYDUS

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE;ORAL	208949-004	Nov 29, 2022	AB2	RX	No	No		⤷ Subscribe				⤷ Subscribe
Zydus Pharms	TOFACITINIB CITRATE	tofacitinib citrate	TABLET;ORAL	209829-001	Mar 13, 2023		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Zydus Pharms	EZETIMIBE	ezetimibe	TABLET;ORAL	204331-001	Jun 12, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Zydus Pharms Usa	HALOPERIDOL	haloperidol	TABLET;ORAL	077580-006	Jan 17, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Zydus Pharms	GLYBURIDE	glyburide	TABLET;ORAL	206749-002	May 10, 2016	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Zydus Pharms	TADALAFIL	tadalafil	TABLET;ORAL	212515-001	Jun 6, 2023		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015128877	⤷ Subscribe
South Africa	201606075	⤷ Subscribe
Philippines	12016501686	⤷ Subscribe
India	651MU2014	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0763039	PA2008009	Lithuania	⤷ Subscribe	PRODUCT NAME: TEMSIROLIMUSUM; REG. NO/DATE: EU/1/07/424/001 20071119
1559427	2013C/040	Belgium	⤷ Subscribe	PRODUCT NAME: MIRABEGRON OU L'UN DES SES SELS; AUTHORISATION NUMBER AND DATE: EU/1/12/809/001 20130107
1666481	PA2017025	Lithuania	⤷ Subscribe	PRODUCT NAME: TOFACITINIBAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS PAVIDALE, ISKAITANT CITRATO DRUSKAAA; REGISTRATION NO/DATE: EU/1/17/1178 20170322
1559427	C 2013 020	Romania	⤷ Subscribe	PRODUCT NAME: MIRABEGRON SAU O SARE A ACESTUIA(2-(2-AMINO-1,3-TRIAZOL-4-IL)-N-[4-(2-{[(2R)-2-HIDROXI9/014; DATE OF NATIONAL AUTHORISATION: 20121220; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/809/001 - EU/1/12/809/014; DATE OF FIRST AUTHORISATION IN EEA: 20121220 -2-FENILETIL]AMINO}ETIL)FENIL]ACETAMIDA; NATIONAL AUTHORISATION NUMBER: EU/1/12/809/001 - EU/1/12/80
1400518	44/2016	Austria	⤷ Subscribe	PRODUCT NAME: SELEXIPAG ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1083 (MITTEILUNG) 20160519
2526934	273 5026-2016	Slovakia	⤷ Subscribe	PRODUCT NAME: IBRUTINIB VO VSETKYCH FORMACH CHRANENYCH ZA- KLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/14/945 20160530
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.